Financial News
Articles published by Veracyte, Inc.
![](https://mms.businesswire.com/media/20240806651491/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces Second Quarter 2024 Financial Results
August 06, 2024
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20240717602722/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240603031308/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240522130721/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240515789405/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240507478547/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240506512666/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240422296304/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240422349293/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240416752482/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240227639570/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240222312513/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
February 22, 2024
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20240221354545/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte to Participate in the Raymond James 45th Annual Institutional Investors Conference
February 21, 2024
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20240208633506/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte to Release Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
February 08, 2024
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20240206436508/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Completes Acquisition of C2i Genomics
February 06, 2024
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20240108004593/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20231212272032/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20231201811059/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20231129259153/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20231122731608/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20231107248167/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces Third Quarter 2023 Financial Results
November 07, 2023
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20231107117656/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients Globally
November 07, 2023
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20231102373163/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte to Participate in the Stephens Annual Investment Conference
November 02, 2023
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20231027584682/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces SITC 2023 Presentations Offering New Insight into Immuno-oncology Drug Development
October 27, 2023
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20231017849913/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20231012548305/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20231004435787/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
New Data from Phase 3 Trial Further Validate Prognostic Value of Veracyte’s Decipher Prostate Genomic Classifier
October 04, 2023
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20230928531630/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20230928392023/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces Multiple Studies Reinforcing the Value of Decipher Prostate Testing Will Be Presented at ASTRO 2023
September 28, 2023
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
![](https://mms.businesswire.com/media/20230927846710/en/1900175/22/Phil_Febbo_Headshot.jpg)
Veracyte Names Phillip G. Febbo, M.D., as Chief Scientific Officer and Chief Medical Officer
September 27, 2023
From Veracyte, Inc.
Via Business Wire
Tickers
VCYT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.